查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613051

秋水仙碱市场：按剂型、年龄、给药途径、销售管道、应用 - 全球预测 2025-2030

Colchicine Market by Dosage Formulation (Liquid, Semisolid Gel, Solid), Age (Adult, Children, Senior), Route of Administration, Sales Channels, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年秋水仙碱市场价值为14.6亿美元，预计到2024年将达到15.8亿美元，复合年增长率为7.85%，预计到2030年将达到24.9亿美元。

秋水仙碱是一种成熟的药物，主要用于治疗和管理痛风和遗传性地中海热等疾病。它的适用性扩展到其他领域，例如心膜炎和心血管疾病的潜在用途，表明其影响范围正在扩大。秋水仙碱的需求在于其在减轻发炎和疼痛方面的有效性，特别是在替代药物有限或具有显着副作用的慢性疾病中。最终用途范围主要包括医院、诊所和居家医疗机构，用于管理需要长期治疗的疾病。秋水仙碱市场受到全球痛风和发炎疾病盛行率不断上升、人口老化加剧以及对其潜在心臟益处的持续研究等因素的影响。此外，对秋水仙碱新治疗应用的认可为相关人员提供了投资扩大研究和开发的绝佳机会，旨在发现新的治疗范例和配方创新。然而，挑战依然存在，包括严格的法律规范、需要仔细医疗管理的潜在副作用，以及可能威胁市场占有率的新型发炎药物的竞争。尤其是给药系统的技术创新潜力巨大，可望提高患者用药依从性、减少副作用，同时也有可能透过循环系统领域的广泛研究发现新的适应症。该市场的特点是成熟，但由于新的应用和配方的进步，具有快速增长的潜力。为了利用新机会，投资研究并与医疗机构合作可以提供竞争优势。同时，公司必须透过确保合规性、患者安全以及向医疗保健专业人员和患者有效传达药物来克服挑战。

主要市场统计
基准年[2023] 14.6亿美元
预测年份 [2024] 15.8亿美元
预测年份 [2030] 24.9亿美元
复合年增长率（%） 7.85%

市场动态：揭示快速发展的秋水仙碱市场的关键市场洞察

供需的动态交互作用正在改变秋水仙碱市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球痛风和心血管疾病盛行率上升
    • 新研究显示秋水仙碱治疗其他发炎疾病的潜力
    • 心血管疾病管理的需求不断增加
  • 市场限制因素
    • FDA核准的製造商数量有限
  • 市场机会
    • 缓释性与联合治疗的开发
    • 增加研发投资以提高药物生物利用度、减少副作用并提高病患依从性
  • 市场挑战
    • 确保病患安全和有效性的监管状况

波特的五力：驾驭秋水仙碱市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解秋水仙碱市场的外部影响

外部宏观环境因素对秋水仙碱市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解秋水仙碱市场的竞争状况

对秋水仙碱市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵秋水仙碱市场供应商绩效评估

FPNV定位矩阵是评估秋水仙碱市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了秋水仙碱市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，秋水仙碱市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球痛风和心血管疾病盛行率上升
      • 新研究显示秋水仙碱可能有效治疗其他发炎疾病
      • 心血管疾病管理的需求日益增加
    • 抑制因素
      • FDA核准的製造商数量有限
    • 机会
      • 缓释性或联合治疗的开发
      • 增加研发投资，以提高药物生物有效性、减少副作用并增强病患依从性
    • 任务
      • 确保病患安全和有效性的监管状况
  • 市场区隔分析
    • 剂量配方：秋水仙碱锭剂的易用性、稳定性和广泛可用性
    • 应用：提高秋水仙碱治疗痛风的疗效和安全性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 秋水仙碱市场依剂量处方

  • 液体
  • 半固体凝胶
  • 固体的

第七章依年龄分類的秋水仙碱市场

  • 成人用
  • 孩子们
  • 进阶的

第八章秋水仙碱市场：依给药途径分类

  • 口服
  • 话题

第九章秋水仙碱市场依销售管道划分

  • 医院药房
  • 网路药房
  • 零售药房

第10章秋水仙碱市场：依应用分类

  • 光化性角化症
  • 白塞氏症
  • 疱疹性皮肤炎
  • 遗传性地中海热
  • 痛风
  • 柏哲氏病

第十一章 美洲秋水仙碱市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区秋水仙碱市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲秋水仙碱市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Endo 推出 Mitigare非专利药“秋水仙碱胶囊”
    • Agefa Pharma 的秋水仙碱获得 FDA核准，秋水仙碱是一种治疗心臟病的古老痛风疗法
  • 战略分析和建议

公司名单

  • AGEPHA Pharma USA, LLC
  • Alchem International Pvt Ltd
  • Ascend Laboratories, LLC
  • Aurobindo Pharma Limited
  • Bio-Techne Corporation
  • bioWORLD by GeneLinx International, Inc.
  • Camber Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Endo International PLC
  • EURO-PHARM International Canada Inc.
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • Hikma Pharmaceuticals
  • Indena SpA
  • LGM Pharma
  • Odan Laboratories Ltd
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Vital Laboratories Private Limited
Product Code: MRR-351BAD503AE4

The Colchicine Market was valued at USD 1.46 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 2.49 billion by 2030.

Colchicine is a well-established medication primarily used for the treatment and management of conditions such as gout and familial Mediterranean fever. Its applicability extends into other areas like pericarditis and potential uses in cardiovascular diseases, indicating a broadening scope. The necessity for colchicine is driven by its effectiveness in reducing inflammation and pain, especially in chronic conditions where alternatives may be limited or have significant side effects. The end-use scope predominantly includes hospitals, clinics, and home care settings where patients manage conditions requiring long-term treatment. The market for colchicine is influenced by factors such as the increasing global prevalence of gout and inflammatory diseases, a growing aging population, and ongoing research into its potential cardiac benefits. Additionally, awareness of colchicine's applications in new therapeutic areas presents potent opportunities for stakeholders to invest in expanded research and development, aiming to uncover new treatment paradigms and formulation innovations. However, challenges persist, including stringent regulatory frameworks, potential side effects requiring cautious medical supervision, and competition from newer anti-inflammatory drugs that may threaten market share. There exists significant potential for innovation particularly in drug delivery systems, which could improve patient adherence and reduce side effects, as well as possible new indications discovered through extensive research in the cardiovascular domain. The nature of the market is characterized by its mature standing with potential spurts of growth driven by novel applications and formulation advancements. To capitalize on emerging opportunities, investing in research and collaborative efforts with healthcare institutions could provide a competitive edge. Meanwhile, companies must navigate challenges by ensuring compliance, patient safety, and effective communication of the drug's benefits to healthcare providers and patients.

KEY MARKET STATISTICS
Base Year [2023] USD 1.46 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 7.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Colchicine Market

The Colchicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of gout and cardiovascular diseases globally
    • Emerging research suggesting the potential of colchicine in treating other inflammatory diseases
    • Growing need of cardiovascular disease management
  • Market Restraints
    • Limited number of FDA-approved manufacturers
  • Market Opportunities
    • Developing sustained-release formulations or combination therapies
    • Rising investment in R&D to improving the drug's bioavailability, reducing its side effects, and enhancing patient compliance
  • Market Challenges
    • Regulatory landscape ensuring patient safety and efficacy

Porter's Five Forces: A Strategic Tool for Navigating the Colchicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Colchicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Colchicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Colchicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Colchicine Market

A detailed market share analysis in the Colchicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Colchicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Colchicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Colchicine Market

A strategic analysis of the Colchicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Colchicine Market, highlighting leading vendors and their innovative profiles. These include AGEPHA Pharma USA, LLC, Alchem International Pvt Ltd, Ascend Laboratories, LLC, Aurobindo Pharma Limited, Bio-Techne Corporation, bioWORLD by GeneLinx International, Inc., Camber Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Endo International PLC, EURO-PHARM International Canada Inc., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., Hikma Pharmaceuticals, Indena S.p.A., LGM Pharma, Odan Laboratories Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Vital Laboratories Private Limited.

Market Segmentation & Coverage

This research report categorizes the Colchicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Dosage Formulation, market is studied across Liquid, Semisolid Gel, and Solid.
  • Based on Age, market is studied across Adult, Children, and Senior.
  • Based on Route of Administration, market is studied across Oral and Topical.
  • Based on Sales Channels, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Application, market is studied across Actinic Keratosis, Behcet's Disease, Dermatitis Herpetiformis, Familial Mediterranean Fever, Gout, and Paget's Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of gout and cardiovascular diseases globally
      • 5.1.1.2. Emerging research suggesting the potential of colchicine in treating other inflammatory diseases
      • 5.1.1.3. Growing need of cardiovascular disease management
    • 5.1.2. Restraints
      • 5.1.2.1. Limited number of FDA-approved manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing sustained-release formulations or combination therapies
      • 5.1.3.2. Rising investment in R&D to improving the drug's bioavailability, reducing its side effects, and enhancing patient compliance
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory landscape ensuring patient safety and efficacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Dosage Formulation: Ease of use, stability, and widespread availability of colchicine tablets
    • 5.2.2. Application: Improved efficacy and safety of colchicine in gout treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Colchicine Market, by Dosage Formulation

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Semisolid Gel
  • 6.4. Solid

7. Colchicine Market, by Age

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Children
  • 7.4. Senior

8. Colchicine Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Topical

9. Colchicine Market, by Sales Channels

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Colchicine Market, by Application

  • 10.1. Introduction
  • 10.2. Actinic Keratosis
  • 10.3. Behcet's Disease
  • 10.4. Dermatitis Herpetiformis
  • 10.5. Familial Mediterranean Fever
  • 10.6. Gout
  • 10.7. Paget's Disease

11. Americas Colchicine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Colchicine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Colchicine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Endo Launches Colchicine Capsules, Generic Version of MITIGARE
    • 14.3.2. Agepha Pharma gets ancient gout remedy colchicine across the FDA finish line for heart disease
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AGEPHA Pharma USA, LLC
  • 2. Alchem International Pvt Ltd
  • 3. Ascend Laboratories, LLC
  • 4. Aurobindo Pharma Limited
  • 5. Bio-Techne Corporation
  • 6. bioWORLD by GeneLinx International, Inc.
  • 7. Camber Pharmaceuticals, Inc.
  • 8. Dr. Reddy's Laboratories Ltd.
  • 9. Endo International PLC
  • 10. EURO-PHARM International Canada Inc.
  • 11. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • 12. Hikma Pharmaceuticals
  • 13. Indena S.p.A.
  • 14. LGM Pharma
  • 15. Odan Laboratories Ltd
  • 16. Pfizer Inc.
  • 17. Takeda Pharmaceutical Company Limited
  • 18. Teva Pharmaceutical Industries Ltd.
  • 19. Vital Laboratories Private Limited

LIST OF FIGURES

  • FIGURE 1. COLCHICINE MARKET RESEARCH PROCESS
  • FIGURE 2. COLCHICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLCHICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COLCHICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COLCHICINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLCHICINE MARKET SIZE, BY SEMISOLID GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COLCHICINE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COLCHICINE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLCHICINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COLCHICINE MARKET SIZE, BY SENIOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLCHICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COLCHICINE MARKET SIZE, BY ACTINIC KERATOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COLCHICINE MARKET SIZE, BY BEHCET'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COLCHICINE MARKET SIZE, BY DERMATITIS HERPETIFORMIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COLCHICINE MARKET SIZE, BY PAGET'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM COLCHICINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2023